Obesity Leaders Dig Manufacturing Moats To Defend Injectable GLP-1 Empires

Leaders at Eli Lilly believe heavy investment in the company’s manufacturing footprint “sets a high standard that newcomers may find challenging to match.” At least one of those newcomers disagrees.

Scroll to Top